Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women

被引:29
作者
Brum, IS
Spritzer, PM
Paris, F
Maturana, MA
Audran, F
Sultan, C
机构
[1] Univ Fed Rio Grande do Sul, Dept Physiol, BR-90050170 Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Div Endocrinol, Gynecol Endocrinol Unit, Porto Alegre, RS, Brazil
[3] Hop Lapeyronie, Serv Hormonol Dev & Reprod, Montpellier, France
[4] INSERM, U540, Montpellier, France
关键词
androgen receptor; postmenopause; testosterone; polymorphism;
D O I
10.1016/j.jsgi.2004.11.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVES: The biologic action of androgens in target cells depends on plasma androgen levels and receptor transcriptional activity. We investigated the relationship between androgen receptor (AR) CAG repeat polymorphism, serum androgen levels, and anthropometric, metabolic, and hormonal variables in 39 postmenopausal women, taken into consideration the patterns of X-chromosome inactivation. METHODS: Genomic DNA was extracted front peripheral leukocytes. Polymerase chain reactions (PCRs) were performed to amplify the polymorphic (CAG)(n) repeat of the human AR gene, which were analyzed with GcneScan software (Applied Biosystems, Foster City, CA). The X-chromosome inactivation analysis was based on the AR gene methylation patterns. RESULTS: The mean age of participants was 54.7 years; mean age at menopause was 48 years. The number of CA G repeats ranged from 15 to 30, with a median length of 23. Analysis of X-chromosome inactivation patterns showed 19 cases with a degree of skewing, (DS) greater than or equal to 70% and seven with a DS greater than or equal to 90%. The X-weighted CAG repeat biallelic mean was significantly lower in individuals with total testosterone (TT) greater than 0.56 ng/mL (group mean) than in the group with TT:;0.56 (P =.018). No difference was observed between the groups regarding dehydroepiandrosterone sulfate (DHEA-S). Plasma TT was signficantly higher in the group, with the smaller X-weighted CAG repeat biallelic mean (P =.01). Free androgen index (FAI) was also significantly higher in this group (P =.033). Testosterone levels and FAI were inversely correlated to X-weighted CAG repeat biallelic mean. CONCLUSION: Our data indicate an association between testosterone plasma levels and AR CAG repeats in postmenopausal women, and suggest that plasma levels of androgens in postmenopausal women may be related to variants of the AR gene.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 50 条
[1]  
ALLEN RC, 1992, AM J HUM GENET, V51, P1229
[2]   Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines [J].
Beilin, J ;
Ball, EMA ;
Favaloro, JM ;
Zajac, JD .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (01) :85-96
[3]  
Belmont JW, 1996, AM J HUM GENET, V58, P1101
[4]   Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer [J].
Buller, RE ;
Sood, AK ;
Lallas, T ;
Buekers, T ;
Skilling, JS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (04) :339-346
[5]  
Burger HG, 2002, FERTIL STERIL, V77, pS3
[6]  
Busque L, 1996, BLOOD, V88, P59
[7]   The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism [J].
Calvo, RM ;
Asunción, M ;
Sancho, J ;
San Millán, JL ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (04) :1735-1740
[8]   ANDROGEN RECEPTOR EXPRESSION IN HUMAN OVARIAN AND UTERINE TISSUE OF LONG-TERM ANDROGEN-TREATED TRANSSEXUAL WOMEN [J].
CHADHA, S ;
PACHE, TD ;
HUIKESHOVEN, FJM ;
BRINKMANN, AO ;
VANDERKWAST, TH .
HUMAN PATHOLOGY, 1994, 25 (11) :1198-1204
[9]   THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION [J].
CHAMBERLAIN, NL ;
DRIVER, ED ;
MIESFELD, RL .
NUCLEIC ACIDS RESEARCH, 1994, 22 (15) :3181-3186
[10]   Clonal haemopoiesis in normal elderly women: Implications for the myeloproliferative disorders and myelodysplastic syndromes [J].
Champion, KM ;
Gilbert, JGR ;
Asimakopoulos, FA ;
Hinshelwood, S ;
Green, AR .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) :920-926